24/7 Market News Snapshot 31 July, 2025 – InspireMD, Inc. (NASDAQ:NSPR)
DENVER, Colo., 31 July, 2025 (www.247marketnews.com) – (NASDAQ:NSPR) are discussed in this article.
InspireMD, Inc. (NSPR) has recently demonstrated notable strength in the market, with its stock opening at $2.43 and currently trading at $2.80, reflecting a substantial increase of 18.14% from the previous close of $2.37. The trading volume has reached 529.55K, indicating strong investor interest that supports the recent price surge. This bullish trend may be attributed to positive developments including significant corporate news. Investors are advised to monitor trading volumes closely, as movements above $2.70 could signal the potential for further gains, while a drop below $2.60 may suggest possible reversals.
In parallel, InspireMD has announced the appointment of Raymond W. Cohen to its Board of Directors. Cohen, with over four decades of experience in the medical technology sector, is expected to enhance the company’s strategic market approach and boost shareholder value. Marvin Slosman, CEO of InspireMD, expressed enthusiasm for Cohen’s joining, citing his operational expertise and strategic insight as vital to the firm’s long-term objectives.
Cohen’s extensive experience includes co-founding Axonics, Inc., which recently achieved a significant $3.7 billion acquisition by Boston Scientific, as well as holding leadership roles in various other influential medical firms. His guidance comes at a crucial time for InspireMD, which is set to launch its CGuard® Prime carotid stent system following recent PMA approval. Designed to prevent strokes, this innovative technology aims to create a substantial footprint in the carotid stenting arena.
Cohen underscored the innovative nature of the CGuard Prime system, asserting that the company’s agility and deep clinical commitment position it strongly within the U.S. carotid stent market. He expressed eagerness to leverage his experience to help InspireMD capture market share and deliver enduring value as it seeks to transform patient care through advanced medical technology.